Trials / Conditions / Malignant Neoplasms Stated as Primary Lymphoid Haematopoietic
Malignant Neoplasms Stated as Primary Lymphoid Haematopoietic
4 registered clinical trials studyying Malignant Neoplasms Stated as Primary Lymphoid Haematopoietic.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Withdrawn | Trial Evaluating the Efficacy and Safety of Daratumumab in Subjects With Relapsed/Refractory B-cell or T-cell NCT03207542 | M.D. Anderson Cancer Center | Phase 2 |
| Completed | Ibrutinib as Early Therapy in Chronic Lymphocytic Leukemia (CLL) NCT03207555 | M.D. Anderson Cancer Center | Phase 2 |
| Withdrawn | Study of Brentuximab Vedotin Plus TAK228 for Relapsed/Refractory Classical Hodgkin Lymphoma, Anaplastic Large NCT03205891 | M.D. Anderson Cancer Center | Phase 1 |
| Withdrawn | Study of Lenalidomide/Dexamethasone With Nivolumab and Ipilimumab in Patients With Newly Diagnosed Multiple My NCT03283046 | M.D. Anderson Cancer Center | Phase 1 |